News

Partner companies' news

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis

Acorn Management Partners, Administrator
April 2022 — 423 views PCSA

Foresight Announces Fourth Quarter and Full Year 2021 Financial Results

Acorn Management Partners, Administrator
April 2022 — 440 views FRSX

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates

Acorn Management Partners, Administrator
April 2022 — 454 views KMPH

Motorsport Games Reports Fourth Quarter & Full Year 2021 Financial Results

Acorn Management Partners, Administrator
April 2022 — 468 views MSGM

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update

Acorn Management Partners, Administrator
April 2022 — 427 views PCSA

Motorsport Games’ rFactor 2 Becomes the Official Sim Racing Platform of Formula E

Acorn Management Partners, Administrator
March 2022 — 501 views MSGM

Motorsport Games Partners with Romain Grosjean to Assist in the Development of rFactor 2 and esports Events

Acorn Management Partners, Administrator
March 2022 — 461 views MSGM

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference

Acorn Management Partners, Administrator
March 2022 — 478 views KMPH

Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST

Acorn Management Partners, Administrator
March 2022 — 420 views PCSA

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial

Acorn Management Partners, Administrator
March 2022 — 455 views KMPH

Motorsport Games to Report Fourth Quarter & Full Year 2021 Financial Results

Acorn Management Partners, Administrator
March 2022 — 405 views MSGM

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)

Acorn Management Partners, Administrator
March 2022 — 433 views KMPH

Foresight to Present and Participate in a Panel Discussion at the Maxim Group Virtual Growth Conference

Acorn Management Partners, Administrator
March 2022 — 460 views FRSX

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference

Acorn Management Partners, Administrator
March 2022 — 438 views PCSA

KemPharm to Report Fourth Quarter and Full-Year 2021 Results

Acorn Management Partners, Administrator
March 2022 — 477 views KMPH

Foresight’s Technology to Replace Use of LiDAR by a Leading Israeli Defense Integrator for the Israeli Defense Forces

Acorn Management Partners, Administrator
February 2022 — 462 views FRSX

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA

Acorn Management Partners, Administrator
February 2022 — 462 views KMPH

Motorsport Games Announces Next Gen Car For NASCAR 21: Ignition

Acorn Management Partners, Administrator
February 2022 — 492 views MSGM

Motorsport Games and Adam Breeden announce global agreement with Formula 1® to create next-level competitive socialising experience, launching in London in 2022

Acorn Management Partners, Administrator
February 2022 — 436 views MSGM

Foresight: Eye-Net Selected by Paris2Connect Consortium to Participate in an Urban Mobility Experiment, Consortium Members Include Nokia, ATC France, Aximum, RATP Group and Signify

Acorn Management Partners, Administrator
February 2022 — 424 views FRSX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives